Verified fact
Dependable information keeps its source and timestamp so it remains inspectable in partner review.
FoundMatter structures company inputs, public sources, and your decision question into a compact evaluation. Facts, founder claims, synthesis, risks, and gaps remain visibly distinct.
Dependable information keeps its source and timestamp so it remains inspectable in partner review.
Deck and founder inputs remain claims until independent evidence supports them.
AI-assisted interpretation is explained and kept separate from its underlying facts.
A strong company can still be wrong for a fund. FoundMatter answers the two questions separately.
Market, product, traction, team, execution, and capital logic are reviewed against available evidence.
Stage, sector, geography, ticket, signals, and exclusions are compared with the actual mandate.
The evaluation closes with the questions and evidence that would materially improve the information state.
Differently presented opportunities enter review through one shared company record.
Evaluation, risks, open questions, and later changes stay on the company instead of scattering across documents.
FoundMatter prepares decisions but does not make them or replace legal, financial, or technical due diligence.
Choose the entry point that matches the current working problem. Every path uses the same structured company record.
FoundMatter can structure deck and company information as part of an evaluation. Claims, sources, synthesis, and missing information remain separate; the result is not an autonomous investment decision.
Yes. Evaluation can start from a specific decision question and show which evidence supports it or what information is still missing.
Company Evaluation remains investor-independent. Match Fit is explained separately against each mandate.
No. It improves first review and decision preparation. Deeper review and responsibility remain with the investor.
Early-stage startup screening from company URL, pitch deck, and public sources, with transparent evidence, risks, mandate fit, and open questions.